# A Study of Patients With HER2 Gene Amplified Metastatic Breast Cancer Treated With First Line Herceptin and a Taxane

> **NCT00097487** · — · COMPLETED · sponsor: **Genentech, Inc.** · enrollment: 1000 (—)

## Conditions studied

- Breast Cancer
- Metastases

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00097487
- **Lead sponsor:** Genentech, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2000-11-30
- **Primary completion:** —
- **Final completion:** 2004-09-30
- **Target enrollment:** 1000 (—)
- **Last updated:** 2018-03-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00097487

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00097487, "A Study of Patients With HER2 Gene Amplified Metastatic Breast Cancer Treated With First Line Herceptin and a Taxane". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00097487. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*